An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
Clinical trial NCT04806529 · WITHDRAWN
Trial details
- NCT number
- NCT04806529
- Sponsor
- Seqirus
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2020-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.